Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 9/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7096990 | 0.83 | ALDH1A1 (0.45) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL7098799 | 0.83 | ALDH1A1 (0.45) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL2062568 | 0.82 | TSHR (0.39) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL3181990 | 0.81 | — | — | |
| SCHEMBL29386852 | 0.81 | TSHR (0.52) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL30102503 | 0.81 | TSHR (0.45) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL29363961 | 0.81 | TSHR (0.45) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL345924 | 0.81 | — | — | |
| SCHEMBL703765 | 0.80 | TSHR (0.52) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| Triethylene Glycol SCHEMBL1506941 | 0.79 | TSHR (0.47) | TSHRALDH1A1TP53HIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120192684-A | Radium-carving conductive black primer and preparation method and application thereof | 东来涂料技术（上海）股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| US-12291510-B2 | 2,5-dimercapto-1,3,4-thiadiazole (DMTD) derivatives | THE LUBRIZOL CORPORATION (US) | 2025-05-06 | — | — | US | disclosed |
| US-11967747-B2 | Redox flow battery electrolytes with 2,5-dimercapto-1,3,4-thiadiazole (DMTD) and its derivatives | THE LUBRIZOL CORPORATION (US) | 2024-04-23 | — | — | US | disclosed |
| CN-113677770-B | Two-part cyanoacrylate/free radical curable adhesive systems | 汉高知识产权控股有限责任公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-111601795-B | Water-soluble 3-coumarin ketone | 意大利艾坚蒙树脂有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-114561010-B | Self-emulsifying nonionic aqueous polyamide imide and preparation method thereof, carbon fiber sizing agent and preparation method and application thereof | 哈尔滨工业大学 | 2023-09-05 | — | — | CN | disclosed |
| CN-116515448-A | Two-part cyanoacrylate/free-radical curable adhesive systems | 汉高知识产权控股有限责任公司 | 2023-08-01 | — | — | CN | disclosed |
| US-20220380326-A1 | 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (DMTD) DERIVATIVES | THE LUBRIZOL CORPORATION (US) | 2022-12-01 | — | — | US | disclosed |
| US-20220320561-A1 | REDOX FLOW BATTERY ELECTROLYTES WITH 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (DMTD) AND ITS DERIVATIVES | LUBRIZOL CORP (US) | 2022-10-06 | — | — | US | disclosed |
| CN-111454397-B | Curable composition, storage container, two-dimensional or three-dimensional image forming apparatus and method | 株式会社理光 | 2022-09-23 | — | — | CN | disclosed |
| CN-114401949-A | 2, 5-dimercapto-1, 3, 4-thiadiazole ('DMTD') derivatives | 路博润公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-114144163-A | Nail coatings based on photocurable compositions | 阿科玛法国公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-114051514-A | Microporous film for bioassay, photosensitive resin composition for forming microporous film for bioassay, and method for producing microporous film for bioassay | 旭化成株式会社 | 2022-02-15 | — | — | CN | disclosed |
| CN-113166589-A | Two-part cyanoacrylate/free radical curable adhesive systems | 汉高知识产权控股有限责任公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-2021055388-A1 | 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (\"DMTD\") DERIVATIVES | THE LUBRIZOL CORPORATION (US) | 2021-03-25 | — | — | WO | disclosed |
| CN-111826242-A | Cleaning solution, method of cleaning semiconductor substrate, and method of manufacturing semiconductor device | 台湾积体电路制造股份有限公司 | 2020-10-27 | — | — | CN | disclosed |
| CN-111601795-A | Water-soluble 3-coumarin ketones | 意大利艾坚蒙树脂有限公司 | 2020-08-28 | — | — | CN | disclosed |
| CN-110770284-A | Film having primer layer containing composite particles comprising organic polymer portion and silicon-containing portion | 3M创新有限公司 | 2020-02-07 | — | — | CN | disclosed |
| US-5104732-A | THERMOPLASTIC SHEET HAVING ENHANCED WATER WETTING AND SPREADING CHARACTERISTICS | GENERAL ELECTRIC COMPANY (US) | 1992-04-14 | — | — | US | disclosed |
| EP-0374516-A2 | Thermoplastic sheet having enhanced water wetting and spreading characteristics and method for making | GENERAL ELECTRIC COMPANY (US) | 1990-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220380326-A1 | 2,5-DIMERCAPTO-1,3,4-THIADIAZOLE (DMTD) DERIVATIVES | DIMT1, PPID, THUMPD1 | TSHR 1640/4885ALDH1A1 2269/4885TP53 2622/4885 |
| US-12291510-B2 | 2,5-dimercapto-1,3,4-thiadiazole (DMTD) derivatives | DIMT1, PPID, THUMPD1 | TSHR 1640/4885ALDH1A1 2269/4885TP53 2622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.